HPA axis & cortisol regulation

What actually decides this outcome, in order of size

Almost everything sold for this pathway is judged against a cortisol number, and the cortisol number is the part that is usually wrong. Ranked by how much of the outcome each one owns:

1. What time it was when the blood was drawn. Cortisol has a steep diurnal profile and a distinct awakening rise, and the awakening response is governed by expert consensus rules about when the samples are taken relative to waking Stalder 2016. A cortisol drawn at 3 pm reports an hour of the day. Two values from different clock times are not a trend, and most of the before-and-after screenshots circulated for this shelf are exactly that comparison.
2. Whether the axis is upstream of the mood or downstream of it. This is answerable, and it has been answered in one direction: a systematic review and meta-analysis found that cortisol measured before onset predicts the later development of depression in adolescents and young adults Zajkowska 2022. That makes HPA activity a risk marker rather than only a consequence, which is the strongest argument this pathway has and the one its own products rarely make.
3. Which presentation it is, because the axis behaves differently across them. Hypothalamo-pituitary-adrenal function has been compared directly between treatment-resistant unipolar and bipolar depression Markopoulou 2021. A single adaptogen recommendation written for everybody with a stress complaint is ignoring a distinction the measurement itself can see.
4. Whether this is pathological hypercortisolism, which is a clinician's question and not a shelf's. The laboratory diagnosis of hypercortisolism has documented pitfalls in both directions Flowers 2023, and a genuinely abnormal result is a referral rather than a purchase. The reciprocal is also true: the glands themselves very rarely fail, and a systematic review of the adrenal-fatigue construct found no support for it Cadegiani 2016.
5. The adaptogens, last, on a timescale of weeks and an effect size measured in questionnaire points. The rhodiola trials that anchor this shelf were run in burnout and in stress-related fatigue Olsson 2009 Shevtsov 2003. These are real randomized results in real populations, and they are questionnaire results. Nothing here moves a diurnal curve back into place inside a week.

The order to run these in, and what has to be true first

Fix the sampling before the shelf, exclude the impostors, then run one adaptogen at a time with a liver panel behind it. Two started together over 8 weeks cannot be told apart afterward.

1. Decide the sampling protocol before drawing anything. A morning Cortisol (AM) taken at a fixed time after waking is interpretable; a convenience draw is not. If the awakening response is the thing being measured, the consensus rules on sample timing are the difference between a result and a number Stalder 2016.
2. Cortisol (AM) with DHEA-S, and ACTH (Adrenocorticotropic Hormone) only if the cortisol is genuinely out of range. DHEA sulfate is the one adrenal analyte a single daytime draw can carry honestly, because sulfation gives it a long circulating half-life and a flat diurnal profile. ACTH is the pairing that separates a pituitary-driven picture from an adrenal one, and it is fragile preanalytically.
3. Exclude the three conditions that imitate this one. TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine), HbA1c (Hemoglobin A1c) for a glycemic swing being read as a stress response, and Ferritin. All three are cheap and all three exist here to come back normal.
4. Then the two behavioral levers, which outrank the shelf. Fixed wake time anchors the awakening response the whole pathway is described by, and cognitive behavioral therapy for insomnia is the first-line treatment where sleep is the driver Wu 2015. Neither is purchasable here and both beat the products.
5. Ashwagandha first among the adaptogens, with a liver panel under it. It has the largest randomized base on this shelf, and it also has a documented hepatotoxicity signal: a scoping review characterizes the clinical presentation of ashwagandha-associated liver injury McIntyre 2026. That is a reason to hold a baseline Comprehensive Metabolic Panel (CMP), not a reason to avoid the plant.
6. Rhodiola if the complaint is fatigue and burnout rather than agitation. The randomized trials were in exactly that phenotype Olsson 2009 Shevtsov 2003, and rhodiola is the more stimulating of the two, which makes it the wrong first choice for somebody already wired.
7. Phosphatidylserine is timed, not daily. Its case is blunting an acute cortisol response, so the exposure has to coincide with the stressor rather than sit at a steady state. A supplement whose argument is acute and whose dosing is chronic is being taken on the wrong schedule.
8. Magnolia Bark, Eleuthero, Holy Basil (Tulsi) and Schisandra are one shelf with four different arguments. Honokiol has a defined receptor target at GABA-A rather than an axis-level story, which is why magnolia behaves acutely and the others do not. Eleuthero has been reviewed for its phytochemistry and its adaptogenic claims Patyra 2025. Stress & Resilience Stack is these components bundled and is judged on them.
9. Selank and GB-115 are mechanism without a Western trial base, and Propranolol is a prescription that does something narrower than people expect. Beta-blockade removes tremor and tachycardia and does not touch the cognitive component. Cortisol Support and Adrenal Cortex come last, for the reason in the next section.

What gets bought for this that cannot move it

Adrenal glandular extracts fail structurally, before any question of efficacy. The premise is that the gland is exhausted and needs replacing, and the systematic review of that construct did not find it Cadegiani 2016. There is also no way to know what is in the capsule: a glandular is a tissue preparation, its active content is undeclared, and any bovine adrenal cortex that did contain physiologically meaningful corticosteroid would be a drug with suppressive effects on the axis it is sold to support.

The four-point salivary cortisol panel is the option here whose marketing most exceeds what it can carry. Salivary sampling is a legitimate research technique and the sampling rules exist for a reason Stalder 2016, but a curve drawn from four convenience samples is not a diagnosis, and the laboratory diagnosis of true hypercortisolism has enough documented pitfalls that it is done by an endocrinologist with dynamic testing Flowers 2023. A shape on a printout is not a gland.

Total cortisol is a binding-protein measurement as much as a hormone one. Most circulating cortisol is bound to corticosteroid-binding globulin, and anything that raises that globulin raises total cortisol without changing the free fraction the tissue sees. Estrogen-containing oral contraceptives do exactly that. A reader on one who is told their cortisol is high is being shown a protein concentration.

And if the axis is not the story, this is the wrong page. Profound fatigue that is worse after exertion and unresponsive to stimulants routes to Energy & fatigue. A flattened curve in somebody whose complaint is tiredness rather than mood routes to Adrenal, cortisol rhythm & stress-driven fatigue, which covers the same axis from the fatigue end. Anxiety without the low mood routes to GABAergic & calming, and a sleep problem driving all of it routes to What's keeping you awake — the upstream causes.

How you would know it was working, on a real read-out and a real timescale

The prediction this page makes is narrow and testable. If the axis is the driver, the morning value and the perceived-stress score should move together across 8 to 12 weeks, sampled at the same clock time. If the score improves and a correctly-timed morning Cortisol (AM) has not changed at all, something else did the work and the adaptogen is not what this page claimed it was.

• Cortisol (AM) at baseline and 12 weeks, same clock time, same laboratory. Twelve weeks rather than four because the adaptogen trials that support this shelf ran on that order of duration Olsson 2009, and because a diurnal rhythm is a habit of the hypothalamus rather than a level to be topped up. Different assays disagree, so a change measured across two laboratories is not a change.
• DHEA-S with the same draw, both times. It is the stable half of the adrenal read-out and it moves slowly, which makes it the number a 12-week comparison can actually support. A falling ratio of DHEA sulfate to cortisol is the pattern this pathway describes, and it is more informative than either value alone.
• Comprehensive Metabolic Panel (CMP) at baseline and again at 8 to 12 weeks if Ashwagandha is running. This is a safety read-out, not an efficacy one. The reported liver injury is idiosyncratic rather than dose-dependent McIntyre 2026, which means it cannot be avoided by taking less and can only be caught by looking. GGT (Gamma-Glutamyl Transferase) adds sensitivity to a cholestatic pattern.
• HbA1c (Hemoglobin A1c) at baseline and 12 weeks. Glucocorticoid tone raises hepatic glucose output and opposes insulin, so a genuinely elevated axis leaves a fingerprint on glycated hemoglobin. The window is 12 weeks because the erythrocyte the assay is measured on lives about 120 days, and a 4-week retest is a misread of the method rather than an early answer.
• ACTH (Adrenocorticotropic Hormone) only alongside an abnormal cortisol, and drawn properly. It is unstable in a warm tube and degrades before the sample reaches the analyzer, so a low ACTH from a room-temperature specimen is a courier problem. Pair it or skip it.

What will fool you. The blood draw is itself a stressor, and a reader who is anxious about needles is measuring the needle. Night-shift work inverts the curve, so a morning value in somebody who woke at 4 pm is their evening value. Estrogen-containing contraception raises total cortisol through the binding globulin without raising the free fraction. And the adaptogen literature is questionnaire-based Shevtsov 2003, so expect the subjective score to move earlier and further than the endocrine one, and do not read that gap as proof the axis changed.

Sources read for these sections

• Zajkowska Z. Cortisol and development of depression in adolescence and young adulthood - a systematic review and meta-analysis. Psychoneuroendocrinology 2022;136:105625 · PMID 34920399
• Markopoulou K. Comparison of hypothalamo-pituitary-adrenal function in treatment resistant unipolar and bipolar depression. Translational Psychiatry 2021;11(1):244 · PMID 33903590
• Flowers KC, et al. Pitfalls in the Diagnosis and Management of Hypercortisolism (Cushing Syndrome) in Humans; A Review of the Laboratory Medicine Perspective. Diagnostics (Basel) 2023 · PMID 37189516
• Cadegiani FA, et al. Adrenal fatigue does not exist: a systematic review. BMC Endocrine Disorders 2016 · PMID 27557747
• Stalder T. Assessment of the cortisol awakening response: Expert consensus guidelines. Psychoneuroendocrinology 2016;63:414-32 · PMID 26563991
• Olsson EM, von Scheele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Medica 2009 · PMID 19016404
• Shevtsov VA, et al. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 2003 · PMID 12725561
• McIntyre D, et al. Ashwagandha (Withania somnifera)-Associated Liver Injury: A Scoping Review of Clinical Characteristics and Safety Considerations. Cureus, 2026 · PMID 42367407
• Patyra A, et al. Eleutherococcus root: a comprehensive review of its phytochemistry and pharmacological potential in the context of its adaptogenic effect. Frontiers in Pharmacology 2025 · PMID 41235111
• Wu JQ, et al. Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis. JAMA Internal Medicine 2015;175(9):1461-72 · PMID 26147487